Patent · US Expired

Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin carboxylate

US6503919B1 · kind B1 · utility

1Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2000
Grant dateJan 7, 2003
Priority date
Expiry dateJun 15, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound selected from those of formula (I): wherein:X and Y represent hydrogen, halogen, hydroxy, mercapto, cyano, nitro, alkyl, alkoxy, trihaloalkyl, optionally substituted amino, methylenedioxy, or ethylenedioxy,R1 represents hydrogen, or alkyl,R2 represents hydrogen, hydroxy, alkyl, alkoxy, alkylcarbonyloxy, or optionally substituted amino,R3 and R4 represent hydrogen, or alkyl,R5 and R6 represent —O—CO—U—V wherein U and V are as defined in the description, or Z as defined in the description, it being understood that at least one of the R5 and R6 groups represents —O—CO—U—V,their isomers, N-oxides, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.